In America, Kratom has always been controversial as it is still not modulated on a national level. Still, it is legitimate to use and obtain in several areas of the United States without any prescription. But, recently, the U.S Senate Committee- Health Education, Labor and Pensions (HELP) has been taking into consideration Mandatory Product Listings. The Mandatory Product Listings would impact all kinds of health food or dietary supplements.
Let’s find out how reasonable this decision is!
Looking At Enacting MPL
The health food market is going rapidly. According to the survey by Council for Responsible Nutrition (CRN), in 2021, nearly 80% of Americans will consume dietary supplements. And since the beginning of Covid-19, the Natural Marketing Institute (NMI) noted that the usage rate of supplements and vitamins has increased.
However, as there is no requirement for central product listing so far, no one knows the actual number of products comprising the dietary supplements market in the U.S. To address this matter and upgrade transparency, the U.S. The Senate is taking steps to enact the mandatory product listing for marketed dietary supplements by placing proposals for two particular bills.
However, the American Food and Drug Administration (FDA) has already requested Congress to pass a law to revise the Dietary Supplement Health and Education Act (DSHEA). They would like it to authorize a program of mandatory product listing. But, the American Kratom Association resists this proposal. They are calling to summon this compulsory filing of dietary supplements.
But why so? How can FDA power over registrations of all dietary supplements harm the kratom industry?
How Does MPL Law Affect The Kratom Industry?
From the starting FDA has objected to using Mitragyna speciosa derived. As a fact, there is no kratom usage, as proved by the Food and Drug Administration of the U.S. Moreover, they have warned consumers to avoid using products that carry Kratom or other psychoactive compounds such as mitragynine or 7-hydroxymitragynine.
In this context, enacting the mandatory filings of dietary supplements would turn the table. It could give the FDA the power to block the back entrance of Kratom. FDA is passively checking out all the scientific information available on this matter. But, the reality is that Kratom has a prolonged history of being used in medicinal purposes where it naturally expands.
Kratom is not an additive, and it is safe to use this mixed with any other substances. And most importantly, as it is a healthy food, the side effects are mild. There is still more research to understand its safety profile, but Kratom is still illegal in several states.
According to Mandatory Product Listings law, manufacturers would be required to come up with the information label of every dietary supplement product produced for selling in the U.S. market. That means an MPL would clear up the path for FDA to crack down on the kratom industry.
However, kratom advocates are trying their best to keep this product legit in America by financing scientific research and speaking in favour of the efforts. And the American Kratom Association urges to oppose MPL for dietary supplements no matter what comes.
Final Thoughts on Mandatory Product Listings
So, all the Kratom fans, to save the kratom industry, let’s not allow the FDA to regulate the mandatory product listing. So, they can not treat kratom supplements as a prescription drug.
And for this step, you just have to go through this link and complete your opposition to not making dietary supplements enlisting mandatory.